Pharmaceutical Industry Updates: Product Applications, Shareholder Meetings, and Financial Performance
①Celltrion applies for European product approval for CT-P47 (Roactemra biosimilar) = Celltrion announced on the 13th that it has applied for European product approval for CT-P47 (Roactemra biosimilar). The indications are △ rheumatoid arthritis △ giant cell arteritis △ systemic type juvenile arthritis △ polyarticular type juvenile arthritis △ cytokine release syndrome △ coronavirus -19 […]
[2023바이오USA/영상] DTNC Group③, “Everyone was impressed”…’The achievements of the MOU and additional meeting at Tokyo Interfex’
-DT&CRO, DT&Nedicals, Hue Science, Safesoft, ’emphasis on customized Full-CRO service’ – Establish CRO strategy with DTNCRO and contacts -Continue detailed discussions such as scale of facility and types of animals… – Additional meeting arranged at ‘Tokyo-Interpex’ in July -We will continue to participate in global exhibitions in the future and ‘grow up’ as ‘CRO Bio […]
Clinomeg “Launched a product for the early detection of colorectal and pancreatic cancer with Singlera in the US.”
Clinomics (CEO Jeong Jong-tae, Kim Byeong-cheol), a company specializing in early cancer diagnosis, announced on the 22nd that it would release an early cancer diagnosis product in the global market in the second half of the year . The company explained that the paid-up capital increase of 44.6 billion won this time was also part […]
